Sands Capital Alternatives, LLC
Q4 2025 13F Holdings
- Locationarlington, VA
- Num holdings
20
- Value ($000)
$518,465
- Date Filed02/13/2026
- Form type13F-HR
- CIK0001846444
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KLAVIYO INC | COM SER A | 49845K101 | $118.51M | 23 % | 3,649,678 | ||
NU HLDGS LTD | ORD SHS CL A | G6683N103 | $114.86M | 22 % | 6,861,399 | ||
BETA BIONICS INC | COM | 08659B102 | $108.78M | 21 % | 3,570,113 | ||
INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | $26.69M | 5 % | 13,018,965 | ||
DOORDASH INC | CL A | 25809K105 | $21.66M | 4 % | 95,618 | ||
COUPANG INC | CL A | 22266T109 | $20.53M | 4 % | 870,424 | ||
SAMSARA INC | COM CL A | 79589L106 | $16.53M | 3 % | 466,190 | ||
DATADOG INC | CL A COM | 23804L103 | $11.67M | 2 % | 85,793 | ||
TOAST INC | CL A | 888787108 | $10.71M | 2 % | 301,647 | ||
BIOAGE LABS INC | COM | 09077V100 | $10.4M | 2 % | 786,353 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100